Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been seen by three expert reviewers, whose comments are copied below. These referees all appreciate your approach and consider the analysis and its results potentially important, but also indicate that the study would require at least some extension to become a good candidate for publication in The EMBO Journal. The most obvious key concern that would need to be satisfactorily reconciled in this respect is the apparent discrepancy between artificial and endogenous chromosomes with regard to centromeric H3K4Me2. Another essential point, as detailed by referees 2 and 3, would be to add some further investigation into the role of transcription, RNA polymerase residency (especially testing the effect of transcriptional inhibition in G1 on CENP-A incorporation as proposed by ref 3), and the currently little investigated but most novel H3K36 centromeric methylation. Finally, to provide better mechanistic understanding I feel that it would be important to investigate potential effects on the CENP-A chaperone HJURP as an obvious candidate, as suggested by referee 1.
Should you be able to extend the investigations along these lines, as well as to address the various more specific technical points (including clarification of some internal inconsistencies) then we should be able to consider a revised version of the manuscript further for publication in The EMBO Journal. I should however remind you that it is EMBO Journal policy to allow a single round of major revision only, and that it will thus be important to diligently answer to all the various experimental and editorial points raised at this stage. When preparing your letter of response, please also bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community in the case of publication (for more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html). Finally, please also briefly indicate the individual author's contributions, either in the acknowledgements section or in an adjacent separate section, as we are also attempting to make this a common policy now. In any case, should you need feedback on any issue regarding your revision, please do not hesitate to get back to us.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
Centromeric chromatin has a unique nucleosomal organization that includes interspersion of nucleosomes that contain either CENP-A or H3. It was previously shown that H3 N-terminal tails within the centromere are dimethylated at K4. In this present study, the authors demonstrate the K36 is also methylated on H3 nucleosomes that are interspersed with CENP-A. Using a synthetic human artificial chromosome (HAC) to which specific proteins can bet tethered, the authors show that LSD1, the H3K4 demethylase depletes the synthetic centromere of H3K4me2 and causes progressive destabilization of the artificial chromosome that correlates with the disappearance of CENP-C and eventually CENP-A. This is an interesting study, with beautiful immunocytology, that offers new information regarding histone modification within human centromere and supports a role for chromatin organization in centromere maintenance. The study falls short in that it does not offer a more clear or direct mechanism for why H3K4me2 and H3K36me2 are involved in CENP-A loading or maintenance at centromere.
Major issues to be addressed.
1. If I understand correctly, different cell line backgrounds were used in these studies. It would be helpful to have a context for why HeLa cells were used in some instances and HT1080 were used in others. For instance, in Figure 1 C-C", HT1080 metaphases and chromatin fibers are shown with H3K36me2 antibody staining, but in subsequent figures showing results with HAC 1C7, it is a HeLa background. Was the interspersed pattern of CENP-A and H3K36me also observed at endogenous HeLa centromeres? 2. Do the authors know if H3K4me2 and H3K36me2 are present on the same nucleosome? In other words, did they ever immunostain chromatin fibers for both modifications or, even better, do ReChIP?
3. When H3K4me2 and H3K36me2 are depleted on the HAC, does unmodified H3, or another modified histone, take their place? The authors showed that H3K27me is present on the alphoidtetO of a normal HAC (Supp Figure 1) ; does this modification increase when LSD1 is tethered to the HAC? Is there a difference in the modifications that replace H3K4me2 and H3K36me2 in the tetR-EYFP-LSD1WT versus tetR-EYFP-LSDK661A? These constructs were used to differentiate between active versus indirect loss of H3K4 methylation so it is possible that the chromatin environment may be altered differently between the experimental models.
4. I appreciate the value of the measurements for CENP-A fluorescence intensity in interphases after H3K4me2 was depleted. Why were CENP-A ChIPs not performed as well? Along the same lines, I'm unenthusiastic about making conclusions about enrichment of histone modifications in interphase cells. For this reviewer at least, the ChIPs were more convincing for showing depletion of particular histone modifications.
5. H34me2 and H3K36me2 were depleted on the HAC using K661A, the catalytically inactive version of LSD1. CENP-A levels also decreased and the authors attribute this to decreased transcription. Were CENP-A-SNAP-tag experiments performed in this case and was it verified that new CENP-A was not loaded similar to the LSD1WT experiments?
6. How did, or should I say, did the authors normalize transcript levels to genome copy number at the endogenous centromere 21? Is it clear that CENP-and H3K4me2/H3K36me2 are present along the entire length of the HAC? At endogenous centromeres, it has been reported that H3K4me2/CENP-A chromatin and H3K9me chromatin can be assembled on different portions of alpha satellite DNA. Do the authors know if transcripts on endogenous centromeres and the HACs are actually originating from H3K4me2/H3K36me2 chromatin? This could be verified by doing RNA-ChIPs.
7. It would be helpful to clarify "short-term" from "long-term". Loss of H3K4me2 appears to immediately affect loading of new CENP-A, as shown by the lovely SNAP-tagging experiments. Yet in Figure 2D -D", the interpretation is that levels of CENP-A appear normal, and a noticeable decrease in CENP-A is not observed by fluorescence (Figure 3 ) until day 5 (or day 3 for CENP-C). The authors should explain what appear to be inconsistencies in results or data interpretation.
8. Is it loss of H3K4me2, loss of H3K36me2 or both that is important for centromere maintenance/CENP-A replenishment? And is the loss of transcription most important? Recent results in plants suggest that RNA-CENP-C interactions are important for centromere architecture. Also, there is no mention anywhere (experiments, discussion) of the potential effect of H3K4me2 on HJURP-CENP-A interactions. Is HJURP, a CENP-A chaperone, unable to bring CENP-A to centromeres when H3K4m2 is depleted? This would be quite exciting if it was known that HJURP (or other loading factors) uses the surrounding chromatin as a marker for where to bring new CENP-A.
9. One concern regarding the tethering assay in general is that some of the contributors to this present work have previously shown that too much transcription is detrimental to centromere function. They've also shown in previous papers, as well as in this study, that too little transcription is toxic to centromeres. Is it possible that the synthetic HAC is just exquisitely sensitive to ANY disruption to chromatin? As I am sure these authors know, the "money" experiment would be to show that loss of H3K4me2 at an endogenous centromere leads to a similar outcome to what they've shown for the HAC.
Minor comments:
1. The authors refer to H3K4me0 on page 6 and in Supp Figure 1 . Do they truly mean unmodified H3K4? 2. I found the various bar color-coding in Figure 2 to be difficult to follow at first. Might it be possible to keep the solid color-coding for the 3 genomic sites across each timepoint, but denote the different timepoints along the x axis? It was very distracting to keep looking back at the legend to remember what condition or site each striped bar represented.
3. A bit more information about which chromosomes are represented in the Figure 6 insets would be helpful. Figure 1B , what is the non-centromeric/non-HAC control for the effect of actinomycin D on transcription?
In Supp
Referee #2 (Remarks to the Author):
Review for Bergmann et al
In metazoans, centromeric domains are defined by alternating arrays of CENP-A and H3 nucleosomes. Earlier work has shown that the H3 domains within the centromere are specifically modified at H3K4Me2, a mark associated with actively transcribing genes. This puzzling finding has led to the hypothesis that this particular modification plays an active role in centromere function. The present study aims to test this model using a novel human artificial chromosome composed of arrays of human alpha satellite DNA, previously shown by the same group to reconstitute centromeres faithfully. The findings of the current work are that H3K4Me2 is indeed enriched on the HAC centromere. In addition, the authors find a new histone mark, H3K36Me, which is also associated with actively transcribing genes, within both the HAC and human 21 centromere. They go on to test the functional requirements of H3K4Me2 using a tethered form of LSD1, specifically demethylating H3K4Me2 at the HAC. They show that under these conditions, for the short term (<2 cell cycles), the centromere is unaffected even though transcription is immediately reduced, indicating that H3K4Me2 is not directly required for mitosis. However, in the longer term (>4 cell cycles) they observe that CENP-A incorporation is diminished leading the loss of centromere function.
Overall, this is an interesting set of findings, taking the previously established HAC one step further to dissect contributions of centromere domain towards mitotic function vs. epigenetic inheritance. A particularly nice result is the finding that H3K4Me2 appears linked to new assembly rather than directly linked to mitotic function. Furthermore, the authors make the argument for an "open" chromatin fiber at the centromere, as these two marks are affiliated with transcriptional activity, and thus unlikely to reside in a closed heterochromatic fiber. This new model is appealing and consistent with recent high-resolution light microscopy work from the senior author and others laboratories. As such, this manuscript represents progress towards the important question of how histone marks effect their function in the centromeric fiber.
However, there are a fair number of issues that must be addressed in order for the study to effectively make the points stated by the authors, as listed below.
Major points 1. The most critical missing piece of evidence is a direct link between polymerase and H3K4Me2. The authors show that transcription of alpha satellite sequences is diminished in actinomycin D treatment and in the LSD-tagged HAC. However, there is no direct evidence that polymerases reside in the centromere of the HAC. This key data that would directly support the title and main claim of the paper, that centromeres resemble 3' ends of actively transcribing genes especially given that acetylation marks are missing. It should be feasible to do a pol CHIP at HAC and ask if it is enriched in when H3K4Me2 is present, and lost in the LSD-tagged, in direct confirmation of the model proposed. 2. The authors make a novel discovery in the finding that H3K36Me is found at HAC and in chr 21 centromeres-however, no additional data or discussion is presented in the manuscript about H3K36, and what it might be doing in the HAC. The entire ms is dedicated to H3K4Me2. Do the H3K36Me and H3K4Me2 domains overlap? Are they entirely independent or mutually exclusive? Is H3K36Me dependent on transcription as well (see pt. 1). It would be nice to see more about the novel modification rather than just the previously documented one. Another technical issue is that H3K36 values in fig1B vs. fig 2C look figure 2C -which is inconsistent with fig 1B. 3. A key problem is the claim that H3K4Me2 is confirmed as a centromere domain marker-this is certainly true for the HAC. However, the real time PCR of ChIP for chr 21 centromere expt shows barely any H3K4Me2 over background. This is in direct contrast to Blower et al's findings, and needs to be discussed. Is chr 21 unique? Or, is the fiber stretching data contrary to real-time PCR/CHIP for technical reasons? An explanation should be provided, and the potential discrepancy discussed in light of the rest of the findings in the ms. 4. The use of the phrase "short term" vs. "long term" for H3K4Me2 loss affecting CENP-A is not entirely clear to me. After 1 day, no difference is seen, but after day 5, a dramatic change is seen. It would make sense to present an entire time course (day 1, 2, 3, 4, 5) so that number of cell cycles taken to dilute CENP-A to the point where the cells no longer can grow in the absence of H3K4ME2 can be plotted. This is necessary because in the LSD tag expt, it is claimed that no changes were seen for 3 days after loss of H3K4Me2, whereas in figure 4 (SNAP_tag), it is clear that CENP-A changes start occurring after 1 cell cycle. Therefore, it may simply be a matter of gradual dilution of CENP-A domains, but it needs to be more thoroughly examined. 5. Discussion could be expanded on the role of transcription in the centromere and what this means for centromeric fiber structure.
Minor points 1. The use of C", C"" etc. is visually distracting and unnecessary. The figures should be relabeled linearly as A, B, C, D, E etc as is customary. A number of figures are discussed out of order, making for a confusing read that jumps back and forth. This was distracting as well. 2. The different scale bars used in Fig 1B make it difficult to assess enrichment across the experimental conditions. Given that all data are standardized to input, perhaps it would be more appropriate to use the same scale bar for homogeneity and ease of comparison.
Referee #3 (Remarks to the Author):
Bergmann et al., use the HAC, developed by the Masumoto, Larionov, and Earnshaw labs, harboring alphoid DNA with engineered tet operator sites. They have established cell lines with stable HACs and used this system in a couple of studies where they target various tet repressor fusion proteins to test the effects of this perturbation on centromere composition and function. The initial description of their system was published in Developmental Cell and represented a borderline heroic effort in its construction, and also showed that transcriptional repressors (and activators, to a lesser extent) could dislodge centromeric proteins and disrupt the stability of the HAC through mitotic divisions. In the present study, the authors target the histone tail demethylase, LSD1, to the HAC and find that it demethylates histone H3 locally on the HAC at sites adjacent to nucleosomes containing the H3 variant, CENP-A, reduces transcription of alpha-satellites, lowers the cell cyclecoupled assembly of new CENP-A nucleosomes, which eventually leads to a reduced quantity of CENP-A nucleosomes at the HAC centromere, and leads to HAC instability. A major limitation of the study is that it is extremely difficult to discern which aspects are reflective of bona fide centromere behavior and which are due to the artificial nature of the system. The HAC alphoid template has, I believe, 1 binding site per 340 amino acids or so (i.e. enough room for one or two nucleosomes plus CENP-B [plus other centromere binding proteins?]). Yes, the authors have reported that tet-YFP alone has no ill effect on the centromere, but in the present study, the main control is not quite satisfying, since the catalytically dead LSD1 still has a profound affect on chromatin modifications and transcription of the HAC satellites. So, if their model is correct, then the catalytically dead mutant will eventually kill CENP-A recruitment and centromere function, too, just on a slightly longer timescale. On the other hand, the broader issues that the authors pursue are difficult ones to attack experimentally, and the authors would be well served to extend what they learn on the HAC to experiments with natural centromeres. A simple experiment, apparently within their grasp (and which would bolster enthusiasm of this reviewer, if successful), would be to assess if transcriptional inhibition by actD treatment in G1, affects the new CENP-A centromere accumulation with the Jansen SNAP experiment.
Other points: 1. It would be helpful to the reader to get a feeling for roughly (or better yet, precisely) how many copies of LSD are recruited to the entire HAC in the various expression ranges, how many copies of alpha-satellite, tet operator sites, etc. How the levels of LSD1 correspond to the total number of conventional and CENP-A nucleosomes would be helpful information in assessing this work. 2. The title is very confusing. Downstream regions of transcribed genes lack CENP-A, for instance, as the Warburton lab has shown. Are the authors alluding to the demonstration that, in addition to CENP-A, HACs also have H3K4me2 which is also found in genes? A title capturing the functional consequence of chromatin modifications at centromeres, if indeed they find one, would be far more appropriate to show they have substantially advanced our knowledge past the earlier description of interspersed chromatin domains by Sullivan and Karpen. 3. It is intriguing how dis-similar the chromatin landscape is on HACs versus endogenous centromere 21 from Fig. S1 , but these findings are largely ignored in the text. Most of the chromatin marks deviate between the HAC and chromosome 21 centromere, with major differences obvious in the case of H3K36me1 and H3K9me2. The graph layout is similar throughout the study, so it is not clear to me what rationale is used by the authors to put their stock in one type of difference and not in others. I also don't understand how they determine what is 'clearly above background ' (p. 6.) . For instance, the alphoidtetO for H3K36me1 apparently falls into this category despite being less than 0.5% of input and also less than all the controls shown. To overcome these problems, we isolated the HeLa-HT1080 fusion 1C7. In our original description in MBoC we documented that HAC stability in the absence of selection (i.e. in vivo kinetochore function) in 1C7 is equivalent to that in the HT1080 background. We also specifically demonstrated that in 1C7 cells HAC replication and mitotic stability are unperturbed. Importantly, the HAC centromere chromatin environment is maintained and ChIP studies reveal a similar histone modification profile in both cell lines (Cardinale, Bergmann, et al., Mol Biol Cell 2009) . We also observe comparable patterns of histone modifications associated with kinetochore chromatin when assessed by microscopy of unfixed chromosomes and chromatin fibres (this study, data not shown).
We have now added a statement (p. 8) to highlight that in both cellular backgrounds, the HAC centromere chromatin is essentially preserved: "We expressed this construct in HeLa 1C7 cells, which maintain a single copy of the HAC, display conservation of the HAC centromere-associated chromatin signature (including the interspersed pattern of H3K4me2 and H3K36me2 nucleosomes on kinetochore fibres) and show a similar HAC mitotic stability to the original HT1080 cells Ö. ".
Was the interspersed pattern of CENP-A and H3K36me also observed at endogenous HeLa centromeres?
We performed all immunofluorescence analysis of unfixed mitotic chromosomes and chromatin fibres in both HT1080 and HeLa 1C7. Patterns and localization of histone modifications with respect to kinetochore chromatin were similar, including the interspersed pattern of H3K36me2 nucleosomes with CENP-A nucleosomes. To avoid confusing the reader, we only show our data on HT1080 cells, but we can provide the corresponding HeLa 1C7 images upon request.
Do the authors know if H3K4me2 and H3K36me2 are present on the same nucleosome? In other words, did they ever immunostain chromatin fibers for both modifications or, even better, do ReChIP?
We performed additional experiments following this interesting suggestion. Unfortunately ChIP and Re-ChIP is not straightforward to interpret given the complex repeated nature of centromeres, where the same primers could potentially report on thousands of different nucleosomes. However it was feasible to prepare further unfolded kinetochore fibers and stain them to visualise centromeric H3K36me2 and H3K4me2 in more detail (new data in Fig. 2 ). Although this approach cannot yield single nucleosome resolution, it is clear from the new data presented that these two modifications occupy overlapping areas, but do not show an identical distribution. We therefore suspect that the two modifications of centromeric H3 nucleosomes are unlikely to show an obligate coupling.
When H3K4me2 and H3K36me2 are depleted on the HAC, does unmodified H3, or another modified histone, take their place?
Given the pronounced impact of H3K4me2 depletion on local transcription, we focused our attention on concomitant changes in modifications felt to be associated with chromatin silencing ñ specifically methylation of H3K9 and (in response to this reviewer) H3K27, as discussed in the following paragraph. As shown in Fig. S3A , levels of these modifications are not significantly affected by tethering of LSD1. Certainly other changes might occur, but given the plethora of known histone modifications on at least 70 different amino acids, a complete investigation of downstream changes in histone modifications is beyond the scope of this MS. The authors showed that H3K27me is present on the alphoidtetO of a normal HAC (Supp Figure 1) ; does this modification increase when LSD1 is tethered to the HAC? The reviewer raises an important point, as hyper-methylation of H3K27 is implicated in repressing transcriptional activity at developmentally regulated promoters. We therefore complemented our ChIP analysis of changes in histone modifications at the HAC centromere by assessing levels of H3K27me2 and -me3 following tethering of LSD1. As shown in the new Fig. S3A , we do not detect any significant changes in these modifications after tethering of LSD1.
Is there a difference in the modifications that replace H3K4me2 and H3K36me2 in the tetR-EYFP-LSD1WT versus tetR-EYFP-LSDK661A? These constructs were used to differentiate between active versus indirect loss of H3K4 methylation so it is possible that the chromatin environment may be altered differently between the experimental models.
For the histone modifications analyzed, LSD1 and LSD1(K661A) appeared to affect the HAC centromere chromatin in similar ways, although changes were seen much more rapidly and comprehensively with LSD1WT consistent with its ability to catalyse the rapid demethylation of H3K4me2 (Fig. 3) . The fact that LSD1(K661A) eventually produced effects similar to those seen with the wild type protein is entirely consistent with published observations that the catalytically dead LSD1 binds CoREST and recruits other chromatin silencing factors and bearing in mind the link between H3K4me2 and transcription.
I appreciate the value of the measurements for CENP-A fluorescence intensity in interphases after H3K4me2 was depleted. Why were CENP-A ChIPs not performed as well? Along the same lines, I'm unenthusiastic about making conclusions about enrichment of histone modifications in interphase cells. For this reviewer at least, the ChIPs were more convincing for showing depletion of particular histone modifications.
CENP-A forms a highly stable, non-exchanging component of centromeric nucleosomes. This has been widely confirmed by others through fluorescence pulse-chase experiments, FRAP, saltextraction and SILAC experiments. The number of CENP-A molecules per centromere can therefore be considered constant throughout interphase, and represents a valid target for quantitative investigation. We believe that there are two reasons why quantitative fluorescence (IIF) may be superior to ChIP in looking at this particular issue.
-1-IIF allows us to monitor changes on the level of individual cells. Thus, we could correlate particular effects on kinetochore structure with the level of tethered tetR fusion bound in each cell. This enabled us to perform experiments using transient transfection, where cell-to cell variability in protein expression can be considerable. It might also be argued that IIF is potentially more sensitive towards the loss of a less abundant epitope. -2-We also believe that for centromeric satellite DNA, ChIP may be less accurate than quantitative IIF given: a) the repeat nature of the underlying alphoid DNA sequence which means that single primer pairs report on many different nucleosomes, b) the range of chromatin fragments obtained by sonication and c) evidence revealing that CENP-A nucleosomes are comparatively sparse along type I satellite DNA (Lam et al., PNAS 2006; Ribeiro et al., PNAS 2010; Ohta et al. Cell 2010) . The reviewer obliquely raises another interesting point -the question of whether the histone modification profile at centromeres varies across the cell cycle. This extremely interesting issue will be addressed in future studies. It should be noted that with respect to transcriptional profiling and histone modifications, virtually all published data and data repositories are derived from asynchronous (predominantly interphase) cells.
H3K4me2 and H3K36me2 were depleted on the HAC using K661A, the catalytically inactive version of LSD1. CENP-A levels also decreased and the authors attribute this to decreased transcription. Were CENP-A-SNAP-tag experiments performed in this case and was it verified that new CENP-A was not loaded similar to the LSD1WT experiments?
We believe that the best way to consider these two constructs is that LSD1WT causes an abrupt and acute depletion of H3K4me2, whereas LSD1K661A causes a chronic inhibition of transcription that has secondary effects on the chromatin modification profile. Therefore, to assess CENP-A loading, the clearest results would be obtained looking in the time frame where LSD1WT, but not LSD1K661A demethylates H3K4me2. We performed parallel quench-pulse-chase experiments under these conditions and found that tethered LSD1K661A had a reproducibly much weaker (and statistically insignificant) effect on loading of newly-synthesized CENP-A than tethered LSD1WT. Since at this time point after transfection, tethering LSD1WT but not LSD1K661A abolished H3K4me2 staining at the HAC, this result is consistent with our conclusion that loss of centromeric H3K4me2 impairs loading of CENP-A. We updated Fig. 6 to include these new data.
How did, or should I say, did the authors normalize transcript levels to genome copy number at the endogenous centromere 21?
Transcript copy numbers were determined by real-time PCR of corresponding cDNA. Genomic "template" was quantified in parallel on gDNA extracted from the corresponding cell line. In both cases, the same primers were used. This allowed us to normalise cDNA levels to DNA template abundance ("genomic copy number"). This approach is quantitatively more accurate than e.g. FISHbased calculation of copy numbers, as it controls for differential efficiency of different primer pairs (probes). We amended the corresponding figure legend ( Fig. 1 ): "Expression data is normalized to the copy number of the genomic regions and -actin mRNA levels (see Materials and Methods) and displayed as arbitrary numbers."
Is it clear that CENP-and H3K4me2/H3K36me2 are present along the entire length of the HAC? At endogenous centromeres, it has been reported that H3K4me2/CENP-A chromatin and H3K9me chromatin can be assembled on different portions of alpha satellite DNA. Do the authors know if transcripts on endogenous centromeres and the HACs are actually originating from H3K4me2/H3K36me2 chromatin? This could be verified by doing RNA-ChIPs.
The reviewer raises a challenging question of the origin of centromeric alphoid transcripts. Due to the nature of the highly repetitive centromere DNA spanning several hundreds or thousands of kilobases, we have yet to devise a successful strategy for mapping the transcription initiation site. RNA immunoprecipitation can be used to determine the direct association of a given transcript with a protein. Through crosslinking, it is possible to "capture" elongating RNA polymerase and its nascent transcript in the proximity of a nucleosome with a certain modification. However, because of the repeat nature of centromere DNA (and therefore transcribed RNA), this cannot be used to determine the origin of the alphoid transcript. In response to the reviewerís suggestion, we performed RNA-ChIP against H3K36me2. The resulting new data (Fig. S1 ) support our primary findings that alphoid transcripts from both the HAC and endogenous chromosome 21 centromeres are indeed associated with this transcription elongation-associated modification. We remain very interested in further characterizing centromeric transcription, including the question of its origin in future studies. Figure 2D -D", the interpretation is that levels of CENP-A appear normal, and a noticeable decrease in CENP-A is not observed by fluorescence (Figure 3 
It would be helpful to clarify "short-term" from "long-term". Loss of H3K4me2 appears to immediately affect loading of new CENP-A, as shown by the lovely SNAP-tagging experiments. Yet in

) until day 5 (or day 3 for CENP-C). The authors should explain what appear to be inconsistencies in results or data interpretation.
We appreciate the reviewerís concern about using the term "normal kinetochore structure" in association with our findings in the context of Fig. 2 (now Fig. 3) , and the confusion this may cause to the reader in light of our SNAP-tag findings. We therefore re-phrased this paragraph accordingly (p.9) "The distribution of CENP-A at the HAC kinetochore appeared normal at both interphase and mitotic HACs at day 3 after doxycycline wash-out ..."). We emphasize that in agreement with the early-onset loading defect suggested by our SNAP-tag data, LSD1-tethered HAC CENP-A levels at this time point are already reduced (therefore not inconsistent with the CENP-C data). We included the corresponding quantification ("day 3") in the full time course for LSD1 tethering reproduced in Suppl. Fig. 3B . Our revised text attempts to make it clear that despite the depletion of H3K4me2, the kinetochore remains functional and structurally intact, in that it supports chromosome bi-orientation and segregation, and staining for CENP-A (and CENP-C) remains "ball-shaped", respectively.
Is it loss of H3K4me2, loss of H3K36me2 or both that is important for centromere maintenance/CENP-A replenishment? And is the loss of transcription most important?
This is a very interesting point. Unfortunately, the mutually dependent and close links of K4 and K36 methylation with ongoing transcription do not allow us to differentiate the role of these two modifications individually. Our newly-added data (Fig. 7) assessing global CENP-A loading after acute short-term exposure to the transcription elongation inhibitor Actinomycin D suggest that a process or state downstream of RNA polymerase activity (which includes the methylation of H3K4 and H3K36) is important to ensure efficient CENP-A deposition. We now discuss this hypothesis in the main text (p.18): "Together, our experiments are consistent with two possible mechanisms for the relationship between H3K4me2 and CENP-A assembly at kinetochores. ÖÖ. However, our studies reveal that acute inhibition of transcription during the cell cycle window in which CENP-A is loaded has a milder impact on CENP-A loading than prolonged targeting by the chromatinmodifying enzyme LSD1. We therefore favour a model similar to that shown in Figure 8 in which RNA polymerase activity indirectly maintains a chromatin state that promotes the binding of HJURP, and therefore the subsequent deposition of newly-synthesized CENP-A.").
Recent results in plants suggest that RNA-CENP-C interactions are important for centromere architecture. Also, there is no mention anywhere (experiments, discussion) of the potential effect of H3K4me2 on HJURP-CENP-A interactions. Is HJURP, a CENP-A chaperone, unable to bring CENP-A to centromeres when H3K4m2 is depleted? This would be quite exciting if it was known that HJURP (or other loading factors) uses the surrounding chromatin as a marker for where to bring new CENP-A.
What a great suggestion! We performed co-transfection experiments with a fluorescently labeled HJURP construct and found (Fig. 7) that tethering of LSD1 results in reduced / abrogated recruitment of HJURP to the HAC centromere. Thus, changes in the local chromatin environment introduced by LSD1 are incompatible with efficient localization of HJURP. This allowed us to suggest a model for the mechanism by which these histone modifications may regulate CENP-A assembly at kinetochores (new Fig. 8 ). We have a follow-up MS written, though not yet submitted in which we show that drastically increasing the transcription from the alphoidtetO array provides by far the most dramatic and rapid inactivation of the kinetochore that we have seen yet. However, modifying the chromatin to moderately increase transcription within the kinetochore has no observable effect on kinetochore stability. So it is true that kinetochores seem to require a balance of their transcription, but it would probably be overstating it to say that they are "exquisitely sensitive" to any disruption of chromatin. Over the years, we have generated a large variety of enzymatic tetR fusions, including histone modifying activities, many of which do not appear to affect HAC centromere structure or function (Cardinale, Bergmann et al., Mol Biol Cell 2009; and unpublished data) . We agree with the referee as to the interest of the "money experiment" but would be interested to know how such an effect could be achieved on a single "natural" centromere. Indeed ñ this ability to specifically manipulate a single kinetochore is a considerable strength of our synthetic HAC system. We replaced "H3K4me0" with "unmethylated H3K4". Figure 2 to We amended the color coding in Fig. 2 (now Fig. 3 ) and hope this makes the figure easier to follow. Figure 6 insets would be helpful. We have amended the legend (now Fig. 5 ) to read "Arrowheads indicate the HAC, also shown in the insets". Figure 1B , what is the non-centromeric/non-HAC control for the effect of actinomycin D on transcription? We monitored both actin and BSr transcripts, and this is now stated in the figure legend. However, levels of these are not reduced to "0", most likely due to the higher stability / abundance of these transcripts. To avoid confusion to the reader, these data were not shown. We amended the corresponding figure legend to read "Under these experimental conditions, levels of -actin and Bsr mRNA were severely reduced (data not shown)". In response to this suggestion, we performed ChIP using an antibody against total RNA PolII both in the presence and absence of tethered tetR-EYFP-LSD1 (new Fig. S6 ). We found low but significant levels of RNA PolII associated with the HAC centromere DNA that were abolished following tethering of LSD1. In new experiments, we extended our characterization of centromeric nucleosome methylation by co-staining of kinetochore fibres for both, H3K36me2 and H3K4me2, as well as H3K36me2 and H3K4me3 (see Rev. 1 point 2; new Fig. 2) . We also extended our discussion about possible implications of local H3K36 (p. 17): "Our data show that repression of transcription at the HAC centromere following tethering of either wild-type or mutant LSD1 is paralleled by a gradual decrease in the levels of the elongation-associated H3K36me2 mark. Recent studies in yeast highlight an important role for H3K36 methylation in the maintenance of chromatin architecture: ÖÖ In light of the hypo-acetylated state and depletion of the H3K4me3 mark from centromeric nucleosomes, local H3K36 methylation may likely be integral to a similar pathway acting to maintain local chromatin architecture. Perhaps in cooperation with interspersed H3K4me2 nucleosomes, methylated H3K36 may form a chromatin environment that directly or indirectly facilitates interaction with the CENP-A deposition machinery…."
One concern regarding the tethering assay in general is
I found the various bar color-coding in
A bit more information about which chromosomes are represented in the
In Supp
The authors make a novel discovery in the finding
Is H3K36Me dependent on transcription as well (see pt. 1). It would be nice to see more about the novel modification rather than just the previously documented one.
A direct link between methylation of H3K36 and ongoing transcriptional elongation is now well accepted (see references p. 12). Our finding that K36 methylation levels at the HAC centromere are gradually reduced during chronic exposure to LSD1(K661A), which represses transcription, but cannot directly demethylate H3K4me2, strongly favors the idea that maintenance of centromeric H3K36 methylation depends on transcriptional activity. This is consistent with published findings obtained from the ORF of transcribed vs. repressed genes. We have also included new RNA-IP data that links centromeric transcripts to H3K36 methylation (new Fig. S1C ).
Another technical issue is that H3K36 values in fig1B vs. fig 2C look different for chr. 21. Chr 21 looks not at all enriched in H3K36 in figure 2C-which is inconsistent with fig 1B.
ChIP values in Fig. 1 represent the "raw" % of Input values, whereas ChIP values in Fig. 2 (now Fig. 3) were normalized to the 5S rDNA locus to allow for better relative comparison across different time points. In addition, the stable 1C7-LSD1 cells assessed in Fig. 2 (now Fig. 3 ) represent a sub-clone of the 1C7 cell line expressing LSD1WT, and subtle differences in absolute values of precipitated material may have occurred. Importantly, based on the raw data for this experiment, levels of H3K36me2 at the chromosome 21 locus were clearly enriched over unspecific IgG, consistent with the data presented in Fig. 1. 
A key problem is the claim that H3K4Me2 is confirmed as a centromere domain marker-this is certainly true for the HAC. However, the real time PCR of ChIP for chr 21 centromere expt shows barely any H3K4Me2 over background. This is in direct contrast to Blower et al's findings, and needs to be discussed. Is chr 21 unique? Or, is the fiber stretching data contrary to real-time PCR/CHIP for technical reasons? An explanation should be provided, and the potential discrepancy discussed in light of the rest of the findings in the ms.
Based on real-time PCR, the HAC alphoid PCR target is about 10 times less abundant than that of chr21. Variations in the repeat unit number across individual chromosomes will therefore ultimately affect the "% of Input" value in ChIP experiments, which in case of centromeres and other repeat loci provides a quantitative "average" rather than an "absolute" value. The fiber FISH data presented by Blower et al., which show association of H3K4me2 with some, but not all of the centromeric alphoid DNA, is therefore not contradictory to our ChIP data and represents differences underlying the technical approaches employed. In response to this and other comments of the referees, we have now also performed IF staining against H3K4me2 on fibres and detect this mark in the vicinity of and interspersed with CENP-A nucleosomes, but at lower density than, for example, H3K36 methylation (new Fig. 2) . We have adjusted the relevant section in the text to emphasize these technical differences (p5-6): "Similar levels of these histone modifications were also seen at the centromere of chromosome 21 with the exception of H3K4me2, which was present at lower levels (Fig. 1B) . H3K4me2 was previously found to be interspersed with CENP-A at active centromeres (Sullivan & Karpen, 2004) , so the difference between the HAC and chromosome 21 data could conceivably reflect the presence of heterochromatic monomeric alphoid 21-II sequences flanking the kinetochore in the endogenous array or be due to other properties of the chromosome 21 alphasatellite array (Ikeno et al, 1994; Masumoto et al, 1998) .". Whatever the explanation is, it is important to note that kinetochore function on the HAC, as determined by its mitotic loss rate, is comparable to native human chromosomes. Thus, even if this is a slight difference in this model system, the kinetochore function is preserved.
The use of the phrase "short term" vs. "long term" for H3K4Me2 loss affecting CENP-A is not entirely clear to me. After 1 day, no difference is seen, but after day 5, a dramatic change is seen. It would make sense to present an entire time course (day 1, 2, 3, 4, 5) so that number of cell cycles taken to dilute CENP-A to the point where the cells no longer can grow in the absence of H3K4ME2 can be plotted. This is necessary because in the LSD tag expt, it is claimed that no changes were seen for 3 days after loss of H3K4Me2, whereas in figure 4 (SNAP_tag), it is clear that CENP-A changes start occurring after 1 cell cycle. Therefore, it may simply be a matter of gradual dilution of CENP-A domains, but it needs to be more thoroughly examined.
Our extended time course experiment does demonstrate a gradual dilution of CENP-A from the HAC centromere after targeting of the LSD1 fusion construct, consistent with a primary defect in loading of newly-synthesized CENP-A. We did not include this data in Fig. 4 , as the data from the 1, 5 and 7 day time points appeared to make the point clearly and were consistent with the other data presented in that figure. In response to this suggestion we have reproduced the full time course for LSD1 tethering in Suppl. Fig. 3 (see also Rev. 1 point 7 ).
Discussion could be expanded on the role of transcription in the centromere and what this means for centromeric fiber structure.
We extended our discussion to include possible implications of local transcription, but chose to feature the effects of chromatin environment/transcription on HJURP binding, as this seemed to provide a better mechanistic insight (p. 18; for text see Rev. 1 pt 8).
Minor points 1. The use of C", C"" etc. is visually distracting and unnecessary. The figures should be relabeled linearly as A, B, C, D, E etc as is customary. A number of figures are discussed out of order, making for a confusing read that jumps back and forth. This was distracting as well.
We replaced all figure labels with consecutive lettering. Fig 1B make Different antibodies have different efficiencies so that absolute % of input values unavoidably requires different scaling for different antibodies. We amended the corresponding figure legend (Fig. 1B) to point the reader to this fact "Note the different scaling of individual panels reflecting different efficiencies of individual antibodies.".
The different scale bars used in
Referee #3 (Remarks to the Author):
Bergmann et al., use the HAC, developed by the Masumoto, Larionov, and Earnshaw labs, harboring alphoid DNA with engineered tet operator sites. They have established cell lines with stable HACs and used this system in a couple of studies where they target various tet repressor fusion proteins to test the effects of this perturbation on centromere composition and function. The initial description of their system was published in Developmental Cell and represented a borderline heroic effort in its construction, and also showed that transcriptional repressors (and activators, to a lesser extent) could dislodge centromeric proteins and disrupt the stability of the HAC through mitotic divisions. In the present study, the authors target the histone tail demethylase, LSD1, to the HAC and find that it demethylates histone H3 locally on the HAC at sites adjacent to nucleosomes containing the H3 variant, CENP-A, reduces transcription of alpha-satellites, lowers the cell cyclecoupled assembly of new CENP-A nucleosomes, which eventually leads to a reduced quantity of CENP-A nucleosomes at the HAC centromere, and leads to HAC instability. A major limitation of the study is that it is extremely difficult to discern which aspects are reflective of bona fide centromere behavior and which are due to the artificial nature of the system.
We thank the referee for their appreciative comments about our first publication on the HAC. It is first and foremost essential to recognize that HACs are a model system that recapitulate many aspects of natural centromeres but may differ in others. The key fact ñ that the alphoidtetO HAC exhibits a stability under non-selective conditions within the range found for natural human chromosomes in cultured cells by the Tyler-Smith lab ñ must, however be borne in mind. That is, the HAC kinetochore appears to work as well as natural kinetochores. Against the differences that may indeed exist must also be balanced the powerful advantages of the HAC system ñ for example, the ability to modulate the chromatin environment at a single kinetochore without treating cells with drugs or RNAi protocols that will affect all centromeres and may also affect undefined nonchromatin targets.
The HAC alphoid template has, I believe, 1 binding site per 340 amino acids or so (i.e. enough room for one or two nucleosomes plus CENP-B [plus other centromere binding proteins?]). Yes, the authors have reported that tet-YFP alone has no ill effect on the centromere, but in the present study, the main control is not quite satisfying, since the catalytically dead LSD1 still has a profound affect on chromatin modifications and transcription of the HAC satellites. So, if their model is correct, then the catalytically dead mutant will eventually kill CENP-A recruitment and centromere function, too, just on a slightly longer times scale.
In control experiments conducted at the NIH, in Japan and in Edinburgh, we have found that the binding of tetR-EYFP does not interfere with the replication or mitotic segregation of the alphoidtetO HAC. It may be significant that the tetR used in our studies is not derived from the tightly-binding form adapted for use in the new generation tet-On constructs. As stated in our response to point 5 of reviewer 1, we believe that the best way to consider the two LSD1 constructs is that LSD1WT causes an abrupt and acute depletion of H3K4me2, whereas LSD1K661A causes a chronic inhibition of transcription that has secondary effects on the chromatin modification profile. We would have loved to try and create a truly "dead" version of LSD1, and despite a previous publication that it is not possible to remove the TOWER domain (responsible for CoREST binding) from LSD1 without inactivating catalytic activity, we consulted with local structural biologists and made such a deletion. Sadly, this deletion, as reported in the literature, was catalytically inactive against H3K4me2. This dual functionality of chromatin-modifying enzymes is by no means uncommon, and appears to be one of the parameters of the system that one must live with.
We have chosen to turn the CoREST binding of LSD1(K661A) into a strength, as it enables us to separate the results of rapid demethylation of H3K4 from the effects of initiating a transcriptionally repressive environment. This analysis has indeed provided support for our hypothesis that H3K4me2 acts within the centromere as a "memory" of the low level transcription, and that together these factors are required for efficient HJURP binding and CENP-A assembly.
On the other hand, the broader issues that the authors pursue are difficult ones to attack experimentally, and the authors would be well served to extend what they learn on the HAC to experiments with natural centromeres. A simple experiment, apparently within their grasp (and which would bolster enthusiasm of this reviewer, if successful), would be to assess if transcriptional inhibition by actD treatment in G1, affects the new CENP-A centromere accumulation with the Jansen SNAP experiment.
This was an excellent suggestion that prompted us to do an experiment of which we were initially a bit frightened. Of course, we knew that long term treatment with Actinomycin D would kill the cells, and cells that have been stressed by synchronization are often more sensitive to such treatments. Nonetheless, we performed the experiment and hope that our result will indeed bolster the enthusiasm of the referee, as it revealed a modest, but clearly significant effect. Our new experiments demonstrate that short-term (5h) acute transcriptional inhibition results in a significant reduction in the amount of newly-incorporated CENP-A on natural centromeres. These important new data are presented in Fig. 7 and described on p. 14 "Because LSD1 causes a drop in centromeric transcription, we next tested the hypothesis that a brief acute loss of transcription will perturb CENP-A loading at endogenous centromeres. A HeLa line stably expressing SNAP-tagged CENP-A at near-endogenous levels (Jansen et al, 2007) was released from a mitotic (nocodazole) arrest into G1 in the presence or absence of the transcription elongation inhibitor actinomycin D, and the loading of newly synthesized CENP-A measured five hours later ÖÖ In these experiments, quantification of cellular TMR-Star signals revealed a modest but significant decrease in the amount of newly-loaded CENP-A in the presence of the drug compared to control cells (Fig. 7B) . Thus, efficient CENP-A loading requires ongoing transcription.".
Other points:
It would be helpful to the reader to get a feeling for roughly (or better yet, precisely) how many copies of LSD are recruited to the entire HAC in the various expression ranges, how many copies of alpha-satellite, tet operator sites, etc. How the levels of LSD1 correspond to the total number of conventional and CENP-A nucleosomes would be helpful information in assessing this work.
Although it might be possible to provide exact numbers of copies of LSD1 bound, this would have required a major experimental effort that would have been severely limited from the outset by the fact that the number of CENP-A nucleosomes forming an active human centromere is currently unknown. In fact the number of copies of CENP-A at natural human centromeres is an object of active ongoing investigation in the Jansen lab. Therefore, in response to this suggestion by the referee, we included new quantitative data to make the point that given the expression levels of the tetR fusion proteins, the alphoid array is not saturated with bound tetR in these experiments. We have now included direct fluorescence quantification of HAC-bound LSD1 fusion constructs in the background of cell lines expressing the construct at different levels (new Fig. S5 ). Indeed, our data reveal that the amount of steady-state tetR fusion bound to the HAC correlates well with the over-all expression level of the fusion construct. We believe that our observations are most consistent with a dynamic exchange between bound to unbound tetR, although the detailed characterization of this process is not essential for our conclusions, since our study focuses primarily on the consequences of enzymatic action by LSD1. We hypothesize that: 1) over time, essentially every tetO binding site may be occupied with a tetR fusion; however, the residence time will differ depending on the available concentration of unbound tetR fusion; and 2) effects of a tetR fusion therefore may over time affect the entire alphoid array. The outcome of expressing an enzymatic fusion will be determined by the balance of agonistic endogenous activity (here: methylation of H3K4) and that of antagonistic activity (here: LSD1-mediated de-methylation). Quantification of the "snap-shot" ratio of bound LSD1 molecules to local nucleosomes will therefore be less informative than a read-out of effectiveness ñ e.g. the measurement of levels of H3K4 dimethylation which we provide in Fig. 3C .
The title is very confusing. Downstream regions of transcribed genes lack CENP-A, for instance, as the Warburton lab has shown. Are the authors alluding to the demonstration that, in addition to CENP-A, HACs also have H3K4me2 which is also found in genes? A title capturing the functional consequence of chromatin modifications at centromeres, if indeed they find one, would be far more appropriate to show they have substantially advanced our knowledge past the earlier description of interspersed chromatin domains by Sullivan and Karpen.
We have changed the manuscript title in light of our newly-acquired functional data demonstrating a reduction of CENP-A loading upon actinomycin D treatment, plus the demonstration that modulating the HAC chromatin composition perturbs HJURP loading. ' (p. 6.) . For instance, the alphoidtetO for H3K36me1 apparently falls into this category despite being less than 0.5% of input and also less than all the controls shown.
It is intriguing how dis-similar the chromatin landscape is on HACs versus endogenous centromere 21 from Fig. S1, but these findings are largely ignored in the text. Most of the chromatin marks deviate between the HAC and chromosome 21 centromere, with major differences obvious in the case of H3K36me1 and H3K9me2. The graph layout is similar throughout the study, so it is not clear to me what rationale is used by the authors to put their stock in one type of difference and not in others. I also don't understand how they determine what is 'clearly above background
It is first and foremost essential to recognize that HACs are a model system that recapitulates many aspects of natural centromeres but may differ in others. The key fact ñ that the alphoidtetO HAC exhibits a stability under non-selective conditions within the range found for natural human chromosomes in cultured cells by the Tyler-Smith lab ñ must, however be borne in mind. That is, the HAC kinetochore appears to work as well as natural kinetochores. Against the differences that may indeed exist must also be balanced the powerful advantages of the HAC system ñ for example, the ability to modulate the chromatin environment at a single kinetochore without treating cells with drugs or RNAi protocols that will affect all centromeres and may have undefined non-chromatin targets. Bearing the above caveat in mind, we acknowledge the point by the referee that for a few histone marks, the "% of Input" values differ between the HAC and the chr. 21 centromere. We openly discuss this observation and refer to the corresponding modifications in the main text (p. 6, text quoted in response to reviewer 2 pt. 3). We postulate that these differences are mainly due to two reasons: 1) different sizes and organizations of alphoid arrays of centromeres coupled with the inherent limitations in ChIP analysis when performed on repetitive arrays that may have subdomain specialisations (see Rev. 2 point 3); as well as 2) some degree of plasticity between histone modifications. In the context of mammalian centromeres, this has been demonstrated for the "repressive" modifications (i.e. H3K9 and H3K27 methylation), which we also find to be comparatively more variable. The role and variability of different centromeric marks is indeed interesting, and our long-term aim is to establish the particular nature and functions of these in the context of functional centromeres. Regarding the details of our histone ChIP, we routinely compared specific pull-down of a given locus with the background signal obtained after pull-down with unspecific IgG. We first subtracted background IP values from the specific antibody IP. To normalize for differential pull-down efficiencies of different antibodies, we then divided this value by the highest value obtained across all regions assessed. For the alphoid tetO locus, we arbitrarily considered values of equal to or greater than 20% of the maximum IP signal as "enriched" (only H3K9ac, H3K27ac and H3K4me3 fall below this threshold). We acknowledge that H3K36me1 levels are very close to the borderline of this cut-off. However, this did not affect our downstream analysis or interpretation of our subsequent data.
2nd Editorial Decision 12 November 2010
Thanks again for submitting your revised manuscript for our consideration. We have now heard back from the original referees 1 & 2 who had agreed to re-assess your study, and I am happy to inform you that both of them agree that the revision work has lead to some exciting new insights. We shall therefore be pleased to proceed with publication of the manuscript pending some final (and hopefully minor) changes in line of some remaining referee comments and suggestions (most of which have arisen from the newly included data). In this respect, only two points by referee 2 are still of bigger concern -it would be good to hear your response to these issues before we can work out what would be needed to address them adequately within the scope of this final revision round (we could certainly also discuss this by phone if you want). Finally, I agree with referee 2 that a somewhat more accurate title should be found -again we can discuss proposals for this further.
After this final round of modification, we should then hopefully be able to swiftly proceed with further steps towards publication of the paper in The EMBO Journal. I am looking forward to hearing from you.
With best regards,
Editor
Centromeric chromatin has a unique nucleosomal organization that includes interspersion of nucleosomes that contain either CENP-A or H3. It was previously shown that H3 N-terminal tails within the centromere are dimethylated at K4. In this study, the authors demonstrate the K36 is also methylated on H3 nucleosomes that are interspersed with CENP-A. Using a synthetic human artificial chromosome (HAC) to which specific proteins can bet tethered, the authors show that LSD1, a H3K4 demethylase, depletes the synthetic centromere of H3K4me2 and causes progressive destabilization of the artificial chromosome that correlates with the disappearance of CENP-C and eventually CENP-A. In the revision of the original, the authors addressed experimentally almost all of my, and the other reviewers' comments. They have added data that, excitingly, suggest that H3K4me2 is linked to new CENP-A deposition by the CENP-A loading factor HJURP and H3K36me2 that is important for centromeric transcription. As I stated previously, this is a very interesting and well-executed study that extends our knowledge of histone modifications within human centromeres and supports a role for chromatin organization in centromere maintenance. The additional experiments (HJURP recruitment, RNA IP) have strengthened the authors' conclusions. This study will have an important impact on centromere and chromatin biology.
I only have a few remaining issues that should be addressed:
On pages 7-9, the authors perform a set of experiments tethering LSD1 to the alphoidtetO-HAC and show that H3K4me2 is depleted after 3 days, but they conclude that CENP-A and CENP-C staining is normal. They show this in Figure 3 by CENP-A and CENP-C immunostaining at day 3. I agree that there is staining for both of these proteins, and the HAC is segregating with the rest of the chromosomes. But what I find fascinating, and what the authors do not mention really at all, is the quantitation for CENP-A and CENP-C at day 3. In Supp Fig 3B, the amount of CENP-A is 50% of normal. This is also true for the LSD1WT-low tethering experiment. This is very interesting that a centromere with half the amount of CENP-A can still function normally. Is there AFU data for CENP-C at day 3? And does this agree with the amount of CENP-A? In Figure 4 , the longer-term LSD1-tethering experiments, by day 5, the amount of CENP-A is 25%. This data would be useful to move to Figure 3 , to put quantitative measurements with the IF images. I also think the authors should modify their statement in the last sentence of the first paragraph on page 9 to state the data in a bit more detail -that normal levels of K4me2 are required to maintain normal levels of CENP-A. When K4me2 is absent, CENP-A levels are reduced, but amazingly, centromeres can function even with one-quarter to half the amount of CENP-A. I think it's an important result, i.e. defining the relative amounts of these proteins to each other as centromeres lose organization and function in this context.
I love the HJURP experiments and am glad the authors did them! What a great result. It would be useful to include AFU plots rather than rely on visual interpretation of the HJURP immunostaining that has been interpreted as decreased/absent amounts of HJURP at the HAC when LSD1 is tethered/H3K4me2 is depleted. It appears from the IF image in Figure 7E that there is no HJURP staining at all at day 2, but do the authors see gradual depletion of HJURP between day 0 and day 2? And how do the AFUs for HJURP compare to CENP-A IF intensity values for the same experiment?
Comments for Authors The characterization of centromeric domains is essential to understand the mechanism of chromosome segregation, and the HAC, in my opinion, provides a good model for the study of centromeres. As previously noted, this manuscript contains findings of interest to the chromosome field. I appreciate that the authors have put considerable effort into this revision, and strengthened the study. The finding that HJURP and CENP-A are depleted in LSD mutant provides an exciting connection between open chromatin required for polymerase access, the formation of transcripts (although it is unclear if they derive from CENP-A associated regions), and CENP-A assembly.
The requirement for open chromatin (as opposed to solenoidal loops) should be highlighted in the discussion since it supports the planar sheet like model proposed by the senior author in a recent study (Ribiero et al PNAS 2010) .
In addition, the following issues still persist, and should be addressed.
Major points 1) Authors illuminate a novel link between the transcription, centromere structure and posttranslational modifications of histones. They observed that both HAC and alphoid chr.21 transcripts are affected by Actinomycin D. By RNA ChIP, they showed also a relationship between transcription and H3K36me2. However the direct link between transcription, H3K4me2 and CENP-A loading is not convincing for the following reasons:
i) The choice of RNA Polymerase II ChIP analysis is surprising given that the authors are using a Pol 1 inhibitor-which polymerase do they think is involved? As described in Supplemental Figure iii) It seems to me essential to prove the inhibition of the polymerase by RT-PCR or qRT-PCR against target control genes to affirm the polymerase is really knocked down.
iv) The RNA Polymerase II ChIP is not persuasive (fig. S6 ). Authors describe "low but significant levels of RNA Polymerase II associated with the HAC centromeres DNA". However, the standard deviation of RNA Polymerase II ChIP in presence of doxycycline are barely above background, and I didn't find a p-value in support of the claim of statistical significance. v) If the authors wish to claim a link between H3K4me2 and transcripts, a RNA ChIP should be performed for this as well.
2) The low level of H3K4me2 observed on native centromeres seems to me a critical issue given the new title of the manuscript. This modification was shown to be associated with centromeric chromatin by senior author and previous studies (Sullivan & Karpen, NSMB 2004; Ribeiro et al., PNAS 2010) . In both articles, alternation of CENH3-and H3K4me2-nucleosomes blocks were observed. H3K4me2 ChIP-qtPCR should be performed with primers for another chromosomes' centromere-specific satellite if chr. 21 is somehow different (as indicated in the text).
Minor points 1) Clearly, LSD1 targeting to HAC centromere DNA provokes rapid H3K4me2 demethylation and slower H3K36me2 demethylation. It seems to me the ratio of histone modifications at alphoid chr.21 vs. HAC in 1C7 stable cell lines expressing tetR-EYFP-LSD1wt vs. tetR-EYFP-LSD1K661A should be the same if both centromeres are equivalently affected. However, a surprising observation is their difference (for chr 21 H3K36me2: 0.5 in 1C7 tetR-EYFP-LSD1wt cells and 1.5 in tetR-EYFP-LSD1K661A cells). Can the authors clarify why this might be?
2) The choice of normalization between fig. 1 and fig. 3 is now clear. Still, post-translational modifications considered above background or enriched are not that compelling ( fig. 1 and S1 ). The enrichment (ratio >1) is clear for CENP-A, H3K4me1 and H3K36me2 for both alphoidtetO and alphoidchr.21. In contrast, low accumulation of H3K36me3 and H3K4me2 at alphoid chr.21 is observed. Again, accumulation of H3K4me0, H3K27me1, H3K27me3 are not "clearly above background" for HAC considering standard deviation/dynamic range.
3) The new title of the manuscript seems to me not supported by the primary findings that H3K36Me2 is more important for immediate loading rather than H3K4Me2. I'm not sure what Epigenetic Engineering is intended to mean-that HAC is differently engineered compared to native centromeres? Or? A title accurately reflecting the findings might serve better. We do not have a full quantification of CENP-C in the clonal 1C7-LSDWT cell line. In early experiments we did, however, quantify levels of interphase CENP-A and CENP-C in the heterogenous 1C7-LSD1WT cell population from which the cell line was derived. Those data reveal (in contrast to the effect mediated by KAP1, see Cardinale et al MBoC) that CENP-A and CENP-C are lost in parallel over the course of 5 days following LSD1 targeting.
In response to this point and to the points immediately below, we modified the text on p. 10 to read: "The distribution of CENP-A at the HAC kinetochore appeared normal at both interphase and mitotic HACs at day 3 after doxycycline wash-out in 1C7-LSD1WT cells (Fig. 3F-H) , although the levels of CENP-A appeared to have decreased by ~ 50% (Fig. 3E) . CENP-C staining was still present on the HAC although its levels also appeared to have fallen in parallel with those of CENP-A (Fig. 3G , H and data not shown)".
In Figure 4 , the longer-term LSD1-tethering experiments, by day 5, the amount of CENP-A is 25%. This data would be useful to move to Figure 3 , to put quantitative measurements with the IF images.
We thank the referee for this suggestion. The appropriate quantitative measurement to go into Figure  3 is the three day value, which we had put into Suppl. Fig. 3 . We now show the quantitation of CENP-A at days 1 and 3 in Figure 3 (panel E). We have left the analysis of the long-term analysis of effects on CENP-A levels in Figure 4 , where measurements for all experiments, including the catalytically inactive mutant control, can be presented together.
We also modified the text on p. 10 (same paragraph as in our response to the preceding point) to read: "The distribution of CENP-A at the HAC kinetochore appeared normal at both interphase and mitotic HACs at day 3 after doxycycline wash-out in 1C7-LSD1WT cells (Fig. 3F-H) , although the levels of CENP-A appeared to have decreased by ~ 50% (Fig. 3E) . CENP-C staining was still present on the HAC although its levels also appeared to have fallen in parallel with those of CENP-A (Fig. 3G, H We fully accept that there are a great many things to learn about the transcription at centromeres, including the polymerase(s) responsible, the cell cycle regulation, the promoters involved, and of course most important ñ the mechanism by which transcription functions in kinetochore specification. However, those issues are far too substantial to include in this MS, which already tells a complex story, and is approaching the size limits of what can be published in the EMBO J. Indeed answering those, and related points, is the focus of ongoing work in our laboratory. We acknowledge that many of the new experiments suggested below are interesting, but believe that they should most properly be included in follow-up studies focusing in more detail on the regulation and consequences of centromeric transcription.
i) We acknowledge that the use of actinomycin D to inhibit CENP-A assembly, as requested by Referee 3 actually raises many questions. We did, as you know, do the suggested experiment and did find a modest, but reproducible, effect of actinomycin D treatment (at 0.5 µg/ml) on CENP-A assembly. After consulting with experts in the use of the drug, we decided ultimately to remove those results from the MS. We felt that this MS is already sufficiently robust ñ indeed both referees, when they gave their initial favourable opinions of what we had done in revision, mentioned the HJURP result and not the transcription experiment. We will now make a detailed and much expended analysis on the role of transcription in CENP-A deposition the subject of a follow-up MS.
For the record, we do note, however, that at the concentrations used in our study, actinomycin D negatively affects BSr mRNA levels in our HAC-containing cell line. This gene is expressed from a Pol2 promoter, thus this result confirm at least partial inhibition of Pol2. These data are included in the amended Suppl. Fig. S1B .
ii) If, in fact, the authors think pol 1 drives centromeric transcripts,
We do not think this.
then their results are in contradiction with previous published data (Wong et al. Genome Research 2007) , who saw no reduction of centromeric transcripts upon Actinomycin D treatment (6hrs, 0.05&#x00B5; g/mL) .
We respond to the comment even though the transcription experiment referred to by the referee has now been removed. We do not believe that our work is inconsistent with the previous study of Wong et al for three reasons. 1.
Based on our reading of the cited work, Wong et al could not rule out an impact of actinomycin D on low levels of Pol2 transcription. 2.
The cell type, concentration of actinomycin D used, and the treatment period, all differ from our conditions. 3.
Lastly, we use highly sensitive and specific real-time RT-PCR to determine levels of centromeric transcripts. This is more sensitive and quantitatively more accurate than the agarose-gel based semi-quantitative analysis performed by Wong et al.
demethylate the histone directly), consistent with co-transcriptional maintenance of this modification.
The alphoid tetO HAC is a synthetic model system that reproduces many aspects of native kinetochore behaviour in remarkable detail, including protein composition, behaviour in mitosis and ñ most importantly ñ the ability to direct chromosome segregation with normal efficiency (i.e. a chromosome loss rate within limits observed for native chromosomes in cultured cells). As for other powerful synthetic model systems, it cannot be excluded that the alphoidtetO HAC exhibits some slight differences from native chromosomes.
We are confused as to what is controversial here. Using ChIP, we have detected H3K4me2 at the HAC centromere. Finding H3K4me2 at centromeres is hardly controversial: Sullivan and others have completely independent imaging methods to detect the same modification interspersed with CENP-A on human chromosomes, as we recently did in a study of chicken chromosomes (Ribeiro et al., PNAS). Our own fibre IF analysis is also consistent with the previously published work and supports the presence of H3K4me2 at kinetochore chromatin.
We commented in the previous round of revision that the perceived low levels of H3K4me2 at the endogenous chr. 21 centromere may be a technical consequence of the nature of the ChIP method when applied to highly repetitive, multi-megabase DNA sequence arrays. In work submitted elsewhere, we (HM and colleagues) have detected low, but significant, levels of H3K4me2 on centromeric DNA from chromosomes 17, 21, X and Y as well as two independent HACs in HT1080 cells. Thus, we believe that the low levels of this modification we have detected on chromosome 21 may be due to technical considerations. 
Minor points
in 1C7 tetR-EYFP-LSD1wt cells and 1.5 in tetR-EYFP-LSD1K661A cells). Can the authors clarify why this might be?
We replied to this in our response to the first round of reviews, where we stated that ChIP values in Fig. 2 (now Fig. 3 ) were normalized to the 5S rDNA locus to allow for better relative comparison across different time points. In addition, the stable 1C7-LSD1 cells assessed in Fig. 2 (now Fig. 3 ) represent a sub-clone of the 1C7 cell line expressing LSD1WT. It is entirely possible that different clones may exhibit subtle differences in histone modification patterns.
2) The choice of normalization between fig. 1 and fig. 3 is now clear. Still, post-translational modifications considered above background or enriched are not that compelling ( fig. 1 and S1) If we consider that background in our experiments for the alphoid tetO HAC was roughly .02% of input, then we argue that 1%, 0.7% and 0.5% for H3K4me0, H3K27me1 and H3K27me3 respectively, are clearly above this (50-fold, 35-fold and 25-fold above background, respectively). Furthermore, had we plotted our values as "normalized to IgG" as is commonly done, our data would show a >100 fold increase in the enrichment factor. Apart from this consideration, K4me0, K27me1 and K27me3 are not critical for our data interpretation, and were included for the sake of completeness.
Nonetheless, in deference to the referee, we have modified the sentence describing these results by removing the word "clearly". The sentence now reads: "Levels of unmethylated H3K4, H3K36me1, H3K27me1, H3K27me2 and H3K27me3 were all higher on the endogenous chromosome 21 alphoid DNA, but were also detected at the synthetic alphoidtetO centromere at levels above background (Fig. S1A) We do not understand the conclusion of the referee that H3K36me2 is more important than H3K4me2, which is what we have actually targeted with tethered LSD1. We used the term "Epigenetic Engineering" because we believe that this is the first time a specific histone modification has been modified in centromere chromatin with the specific aim of probing and altering function. Hopefully the new title "Epigenetic engineering shows H3K4me2 is required for HJURP targeting and CENP-A assembly on a synthetic human kinetochore" is a suitable mixture of technological and biological information.
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